Pluripotent Stem Cells

Pluristyx offers off-the-shelf NIH-approved PSCs for immediate evaluation in unmodified and disease-affected versions. iPSCs are generated from regulatory-compliant donors and can be evaluated to assist in the selection of line appropriate for your research.

PluriBank PSCs

Pluristyx PSCs are obtained using IRB approved informed consents and reprogrammed with proprietary mRNA methods.  All lines come with Certificates of Testing and have pathways for commercial use.  GMP lines are available upon request.

ESI PSC

Pluristyx is a licensed supplier of the ESI brand of pluripotent stem cells (ESI-017, ESI-035, ESI-049, ESI-051, ESI-053). These NIH-registered pluripotent stem cells were derived under Good Tissue Practices (GTP) and are suitable for use in R&D and in the development of cellular therapeutics.

Pluristyx wild-type and disease-affected PSC

Pluristyx is a licensed supplier of wild-type and disease-affected pluripotent stem cell lines from the University of Michigan.

These NIH-registered lines allow means of studying disease progression and treatments.

PluriBank iPSCs

Human induced pluripotent stem cells were derived under GTP conditions. Cell lines include wild type as well as gene edited versions of the IPSC products where available.  Pluristyx currently provides these cells for research use only. 

For use in research applications, Contact us for GMP grade cell banks.

ESI PSC

ESI human pluripotent stem cells were derived under GTP conditions making them suitable for use in diagnostic and therapeutic applications. Pluristyx currently provides these cells for research use only. 

For use in clinical applications, Contact us for GMP grade cell banks.

Pluristyx PSC

Pluripotent stem cell lines that are wild-type and genetically normal. These lines are NIH approved and available for use in R&D.

Contact us for a full list of available cell lines, availability, and lead times.

Pluristyx Disease-Affected PSC

Pluristyx disease-affected human pluripotent stem cells are NIH approved and available for use in R&D. These lines have an identified genetic abnormality that cause disease and enables research into understanding developmental mechanisms of disease establishment and progression.

Contact us for a full list of available cell lines, availability, and lead times.

Please contact us for more information on GMP cell banks for use in clinical applications

Shopping Cart
Scroll to Top